In AR-A014418-treated mice, Y216-phosphorylation of GSK3β appeared to decrease in the tumors, and membranous expression, but no nuclear accumulation of β-catenin was observed in tumor cells (Fig. 7B). This evidence concerns the gene GSK3B and neoplasm.